MedWorm Sponsor Message: Find out how you can get your message posted here and on over 100,000 other medical web pages in just a couple of days, plus support MedWorm at the same time.
Thursday, June 2, 2011
Mesothelioma Screening Using Plasma Samples May Increase Accuracy of Diagnosis
Biomarkers are one of the most relevant tools for the early diagnosis of mesothelioma. Although the cancer is typically not detected until its later stages, new screening tests look for the presence of these proteins in a patient’s blood or tissue samples to detect mesothelioma.To evaluate the diagnostic accuracy of these tests, an Australian study explored the sensitivity of two blood-based biomarkers, mesothelin and osteopontin, in blood serum and plasma samples from 176 patients. The results showed that plasma samples provided a more accurate biomarker reading than blood serum samples collected from the same patient.To measure the sensitivity of the biomarker content in blood serum and plasma levels, researchers from the National Research Centre for Asbestos Related Diseases at the ...
Subscribe to:
Post Comments (Atom)
New screening tests will be more helpful because if it detect soon then they have time start treatment.
ReplyDeleteMesothelioma
Excellent post and wonderful blog, I really like this type of interesting articles keep it you.Work at Best Chicago mesothelioma lawyer Corp.
ReplyDelete